ArticleBMC cancer2016

Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFR-mutated NSCLC patient and successful management by adding ALK inhibitors: a case report.

Wenhua Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.